SEC approves Nasdaq options tied to index-based prediction contracts
SEC approves Nasdaq MRX index-linked binary options tied to Nasdaq-100, expanding prediction-style trading as exchanges race into event-based markets. » Read more about: SEC approves Nasdaq options tied to index-based prediction contracts »
Read MoreDid Nvidia Just Deliver a Breakout Fake-Out? Why Dip‑Buyers Should Welcome a Dip
Slaven Vlasic / Getty Images Entertainment via Getty Images
Quick Read
-
Nvidia (NVDA) fell 8% below $200 per share after briefly rejoining the $5 trillion club, facing potential weakness to the $170-180 channel as Alphabet (GOOG) closed its market cap gap to $4.6 trillion following a 10% surge on a strong quarterly result.
WATCH LIVE: Powell’s last Federal Reserve interest rate decision before stepping down
Federal Reserve Chair Jerome Powell will hold his final press conference at 2:30 p.m. Wednesday to discuss the policymakers’ interest rate decision ahead of his planned departure on May 15.
The appearance comes at a pivotal moment for the central bank as it weighs whether to change interest rates amid lingering inflation concerns and President Donald Trump‘s demand that rates need to drop.
Read MoreIs Repay Holdings (RPAY) One of the Best Tech Penny Stocks According to Hedge Funds?
Repay Holdings Corporation (NASDAQ:RPAY) is one of the best technology penny stocks to invest in according to hedge funds. On April 17, Repay Holdings confirmed receiving an unsolicited, non-binding proposal from Forager Capital Management LLC to acquire all outstanding shares of the company.
Read MoreStock Market Today, May 4: Oil Spikes and Stocks Fall as Geopolitical Tensions Flare
The Burst
Is Lemonade Stock a Sweet Deal Down 87%
When insurance technology firm Lemonade first debuted on the markets at an official price of $29 before soaring to $66 per share, it was caught up in a frenzy of bullish speculation that subsequently led the stock to rally to $183 per share.
But the excitement wasn’t to last and now the share price sits about 85% lower.
» Read more about: Is Lemonade Stock a Sweet Deal Down 87% »
Read MoreThe Ivy
1 Cash Cow with Massive Upside
CVS Health (NYSE:CVS) share price declined by over 23% over the past twelve months. Hurting shareholders was the recent leadership transition from CEO Karen Lynch to David Joyner, a shift that brought uncertainty to the company’s direction as investors questioned the company’s stability while facing ongoing challenges.
» Read more about: 1 Cash Cow with Massive Upside »
Read MoreThe Spotlight
1 Indicator Has Been Right for 77 Years: What’s It Saying Now
Imagine having access to an indicator that has reliably predicted recessions with high accuracy for almost a century. Surprisingly, there is an indicator that has done just that, without receiving much mainstream attention.
This indicator was recently tallied at the end of February, so what does it say? Interestingly, the indicator’s reading contradicts the predictions of other signals that suggest a lingering bear market.
» Read more about: 1 Indicator Has Been Right for 77 Years: What’s It Saying Now »